公司資料
Evaxion Biotech 股價、新聞與催化劑
- 股票代碼:
- EVAX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Denmark
股票表現
3.22 USD (+6.27%)
收盤價
最後更新: 2026年9月17日
31.3M USD
市值
股價為何變動
截至 2026年9月17日，EVAX 上漲 6.27%，收於 $3.22。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Evaxion Biotech is a biotechnology company focused on AI-enabled vaccine and immunotherapy discovery. Its platform aims to combine computational methods with immune science to create new therapies.
所在地與產業分類
Headquartered in Denmark and listed on NASDAQ as an ADR, Evaxion has a global AI-biotech profile.
商業模式特徵
The company depends on platform adoption, clinical validation, and the ability to convert AI-assisted discovery into pipeline value.
生技產業定位
Evaxion is a hybrid AI-biotech name whose valuation depends on both platform credibility and drug progress.
未來催化劑
- Evaxion’s catalysts are AI-designed vaccine programs and any clinical or partnership update that shows the platform can turn computational design into human value. The next step matters because the company still needs real proof.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。